Lung and HIV

H. Arfaoui (CASABLANCA, Morocco), R. Cherkaoui (CASABLANCA, Morocco), H. Jabri (CASABLANCA, Morocco), W. Elkhattabi (CASABLANCA, Morocco), H. Afif (CASABLANCA, Morocco)

Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised

Session: Fungi, viruses, parasites and the immunocompromised
Session type: E-poster
Number: 1889

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Arfaoui (CASABLANCA, Morocco), R. Cherkaoui (CASABLANCA, Morocco), H. Jabri (CASABLANCA, Morocco), W. Elkhattabi (CASABLANCA, Morocco), H. Afif (CASABLANCA, Morocco). Lung and HIV. 1889

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Lung cancer and HIV infection in a center Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Lung Micobiome in Lung Cancer Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020
Lung Cancer and bronchial infection Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
Lung pathology in COVID-19 Source: Eur Respir Monogr 2021; 94: 86-100 Year: 2021
Lung development Source: Eur Respir Monogr 2021; 91: 1-16 Year: 2021
Lung cancer Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term) Year: 2020
Lung cancer Source: Breathe 2016; 12: 392-399 Year: 2016
Lung cancer Source: School Course 2014 - Pulmonary Rehabilitation Year: 2014
Lung function testing Source: ERS Course 2015 Year: 2015
Lung cancer associated with Pulmonary tubercolosis Source: Eur Respir J 2002; 20: Suppl. 38, 437s Year: 2002